Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Innovotech ( (TSE:IOT) ) has shared an update.
Innovotech Inc. has announced plans to obtain a quotation and trading symbol on the U.S. OTCQB Venture Market while maintaining its primary listing in Canada, aiming to broaden its visibility among American investors and improve liquidity in its shares. The company expects no material increase in compliance or reporting requirements due to its existing foreign issuer disclosure regime and will also seek Depository Trust Company eligibility to simplify electronic clearing and settlement for U.S. investors, a move that could enhance access to Innovotech’s stock for both retail and institutional stakeholders and potentially strengthen its capital markets profile.
More about Innovotech
Innovotech Inc. is a Canadian boutique contract research organization specializing in advanced laboratory services and proprietary technologies in biofilm science. The company offers antimicrobial testing, pharmaceutical analysis, and industrial laboratory solutions, anchored by its widely used MBEC Assay kit for high-throughput antimicrobial and antibiotic testing. Innovotech serves clients across multiple sectors through ISO-certified and GMP-accredited laboratories that meet stringent regulatory standards, including those of the U.S. Food and Drug Administration and Health Canada.
Average Trading Volume: 31,481
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$13.61M
Learn more about IOT stock on TipRanks’ Stock Analysis page.